Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
4.755
-0.095 (-1.96%)
Jul 3, 2025, 4:00 PM - Market closed
Verastem Market Cap
Verastem has a market cap or net worth of $261.28 million as of July 3, 2025. Its market cap has increased by 197.25% in one year.
Market Cap
261.28M
Enterprise Value
220.23M
1-Year Change
197.25%
Ranking
Category
Stock Price
$4.76
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $261.28M, an increase of 22.50%. That is a compound annual growth rate of 1.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 266.50M | 15.82% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.07B |
| Johnson & Johnson | 373.83B |
| AbbVie | 336.02B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 292.29B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.22B |
| AstraZeneca | 221.10B |